Weight Management Program

BEHAVIORAL9 trials

Conditions

Chronic Kidney DiseaseHyperinsulinemiaInsulin ResistanceMetabolic SyndromeObesityOsteo Arthritis Knee and HipOverweightPediatric Obesity

Phase 2

Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial

NCT04274608

Tan Tock Seng HospitalObesity, Weight Loss

Start: 2020-01-01End: 2022-07-31Target: 18Updated: 2020-02-18

Phase 3

Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)

TerminatedNCT01601704

Orexigen Therapeutics, IncObesity, Overweight

Start: 2012-06-30End: 2015-08-31Updated: 2017-02-27

Phase 4

Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

CompletedNCT00485823

Eli Lilly and CompanySchizophrenic Disorders

Start: 2002-12-31End: 2003-09-30Updated: 2007-06-13

Unknown Phase

The Effect of a Weight Management Program During Treatment With Olanzapine

CompletedNCT00169702

Heinrich-Heine University, DuesseldorfSchizophrenia

Start: 2003-06-30End: 2007-07-31Updated: 2008-01-30

Effects of a Comprehensive Weight Management Program on Obese Adolescents and Children

CompletedNCT00409422

Yale UniversityHyperinsulinemia, Insulin Resistance, Pediatric Obesity

Start: 2002-05-31End: 2007-02-28Target: 200Updated: 2008-06-24

Weight Loss Interventions in Obese Patients With Stages 3-4 Chronic Kidney Disease: a Randomised Controlled Trial

CompletedNCT01053130

King's College Hospital NHS TrustChronic Kidney Disease, Obesity

Start: 2010-01-31End: 2013-01-31Updated: 2016-06-09

The Effect of a Multi-component Weight Management Program on Appetite, Food Preference and Body Weight

CompletedNCT02012426

University of LeedsObesity, Overweight, Sedentary Lifestlye

Start: 2014-01-31End: 2016-05-31Updated: 2017-06-01

Exercise Capacity and Dyspnea in Obese Patients With Metabolic Syndrome: Effects of Weight Loss

CompletedNCT03035149

University of OttawaMetabolic Syndrome, Obesity

Start: 2005-05-31End: 2012-07-31Updated: 2018-03-05

Predicting The Right Advice at The Right Time in Patients With Hip and Knee OsteoArthritis: the e-cOAch Cross-over.

RecruitingNCT07423858

UMC UtrechtOsteo Arthritis Knee and Hip

Start: 2025-09-01End: 2027-02-01Target: 600Updated: 2026-02-20

Related Papers

Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial

UNC Libraries2020-04-1823 citations

A Low Energy-Dense Diet in the Context of a Weight-Management Program Affects Appetite Control in Overweight and Obese Women.

2018-05-0118 citations

Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors

JAMA2016-03-08264 citations